In this clinical update from the podcast "This Week in Virology," Dr. Daniel Griffin and Vincent Racaniello discuss several key topics in infectious disease and public health. A major focus is a groundbreaking study published in Nature revealing that SARS-CoV-2 mRNA vaccines can significantly enhance the effectiveness of immune checkpoint inhibitor (ICI) cancer therapies, improving survival rates for patients with certain cancers like melanoma and non-small cell lung cancer. The mechanism is linked to a vaccine-induced type I interferon response that primes the immune system against tumors.
The hosts also review a meta-analysis linking viral infections such as influenza and COVID-19 to a substantially increased short-term risk of heart attack and stroke. Further updates cover current vaccine effectiveness for COVID-19, RSV, and influenza; the ongoing spread of H5N1 avian influenza in U.S. poultry; and the alarming rise in measles cases that threatens the elimination status in the U.S. and Canada. The episode concludes with a Q&A session addressing listener questions on topics ranging from newborn vaccinations to prophylactic treatment for parasitic exposure and shingles vaccine considerations.
TWiV 1266: Clinical Update and Scientific Insights
2:26 Surgeon General Nominee and the Philosophy of Medicine: Dr. Griffin discusses the nomination of Dr. Casey Means for Surgeon General and refutes her stated reason for leaving clinical practice—that doctors only treat complications rather than root causes. He argues that good medical practice, particularly in public health and infectious disease, is fundamentally about identifying root causes and preventing illness.
5:21 mRNA Vaccines Enhance Cancer Treatment: A significant portion of the update is dedicated to a Nature paper showing that SARS-CoV-2 mRNA vaccines can sensitize tumors to immune checkpoint inhibitor (ICI) therapy.
Key Takeaway: For patients with cancers like non-small cell lung cancer and melanoma, receiving a COVID mRNA vaccine within 100 days of starting ICI therapy was associated with a near doubling of survival time and a significantly higher three-year survival rate (from ~30% to ~60%).
Mechanism: The vaccine triggers a type I interferon response, which activates the body's innate immune system to better recognize and prime T-cells against cancer cells. It can also increase PD-L1 expression on tumors, making previously ineligible patients candidates for ICI therapy.
16:17 Viral Infections Increase Risk of Heart Attack and Stroke: A meta-analysis in the Journal of the American Heart Association is discussed, highlighting the link between viral infections and cardiovascular disease.
Details: SARS-CoV-2 infection was associated with a nearly doubled risk of coronary heart disease and stroke. Laboratory-confirmed influenza was even more striking, with a four-fold increased risk of acute myocardial infarction and a five-fold increased risk of stroke in the month following infection.
Key Takeaway: This underscores the importance of vaccination against viruses like influenza and SARS-CoV-2 not only to prevent acute illness but also to reduce the risk of severe downstream cardiovascular events.
19:30 Vaccine Effectiveness Update (COVID, RSV, Flu): A meta-analysis provides updated efficacy data for fall vaccines.
COVID-19: The XBB.1.5 mRNA vaccine showed ~46% effectiveness against hospitalization. Myocarditis risk from the vaccine is very low (1.3-3.1 per 100,000 doses in the highest-risk group) and significantly lower and less severe than from COVID-19 infection itself.
RSV: Vaccines are over 68% effective against hospitalization in adults 60+. There is a small associated risk of Guillain-Barré syndrome (18 cases per million doses).
Influenza: The flu vaccine demonstrated 48% effectiveness in adults and 67% in children against hospitalization.
23:35 H5N1 "Bird Flu" Update: Highly pathogenic avian influenza continues to be detected in U.S. commercial and backyard poultry flocks. Minnesota, the nation's top turkey producer, has been significantly impacted, with millions of birds culled nationwide.
26:11 Measles Epidemic Worsens: The U.S. has now confirmed 1,648 measles cases, while Canada has over 5,100. Both countries are on track to lose their measles elimination status, highlighting the consequences of declining vaccination rates.
28:13 RSV Season Begins: RSV activity is starting to increase, particularly in Florida. Wastewater is not an effective surveillance tool for RSV because its primary targets (children under two) are often in diapers. New data shows that both mRNA revaccination and protein-based RSV vaccines are highly effective.
33:17 Current COVID-19 Vaccine Durability: A study in U.S. veterans showed the 2024-2025 COVID-19 vaccine was 64% effective against death. Another study showed protection against hospitalization or death waned from 57% at 4 weeks to 34% at 20 weeks, though the data has wide confidence intervals.
Hepatitis B Vaccine in Newborns: Newborns have a sufficiently competent immune system to mount a protective response.
Prophylactic Praziquantel: For potential schistosomiasis exposure in Malawi, taking the low-risk medication prophylactically is a reasonable alternative to expensive and complex testing.
Hoof and Mouth Disease: Concern over importing beef from Argentina is primarily economic, not a public health risk, as Argentina is certified free of the disease.
Shingles Vaccine (Shingrix): For a patient with a family history of Alzheimer's, getting the Shingrix vaccine is recommended due to studies linking it to a reduced risk of dementia, which outweighs the risk of a temporary adverse reaction like a sore arm.
Linked Resource Summaries
Nature Article - "SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade": This study demonstrates that COVID-19 mRNA vaccines can significantly improve the effectiveness of immune checkpoint inhibitor (ICI) cancer treatments. In both preclinical mouse models and large retrospective human patient cohorts with melanoma and lung cancer, receiving an mRNA vaccine within 100 days of starting ICI was associated with substantially improved overall survival. The mechanism involves the vaccine triggering a strong type I interferon response, which activates innate immunity and primes T-cells to attack tumor-associated antigens, effectively turning "cold" tumors into "hot" ones that are responsive to immunotherapy.
Journal of the American Heart Association Article - "Viral Infections and Risk of Cardiovascular Disease: Systematic Review and Meta‐Analysis": This comprehensive meta-analysis of 155 studies confirms a strong association between several common viral infections and an increased risk of major cardiovascular events like heart attacks and strokes. Acute respiratory infections, including influenza and SARS-CoV-2, were linked to a sharply elevated short-term risk. Chronic viral infections such as HIV, Hepatitis C, and herpes zoster were associated with a persistent, long-term increased risk. The findings highlight that preventing viral infections through vaccination could be an important strategy for reducing cardiovascular disease.
USDA APHIS Page - "Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks": This is a public-facing dashboard from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) that provides up-to-date information on detections of Highly Pathogenic Avian Influenza (HPAI), or "bird flu," in the United States. It confirms ongoing detections in both commercial and backyard poultry flocks, noting that cases are typically higher during the fall and spring wild bird migration seasons. The page serves as a central resource for tracking the outbreak's impact on U.S. poultry production and emphasizes the need for strong biosecurity measures.
Glossary of Medical Terms
Guillain-Barré Syndrome (GBS): A rare neurological disorder in which the body's immune system mistakenly attacks part of the peripheral nervous system. It can cause muscle weakness, numbness, and in severe cases, paralysis.
Hoof and Mouth Disease (or Foot and Mouth Disease): A severe and highly contagious viral disease affecting cloven-hoofed animals like cattle, pigs, and sheep. It is not a threat to humans but can cause major economic damage to the livestock industry.
Immune Checkpoint Inhibitor (ICI): A type of cancer immunotherapy that works by blocking "checkpoint" proteins on immune cells (like T-cells) or cancer cells. These checkpoints normally prevent the immune system from attacking the body's own cells, but cancer can exploit them to hide from immune attack. Blocking them "releases the brakes" on the immune system, allowing it to recognize and kill cancer cells.
Myocarditis: Inflammation of the heart muscle (myocardium). It can reduce the heart's ability to pump and cause rapid or abnormal heart rhythms. It can be caused by viral infections, including SARS-CoV-2.
PD-L1 (Programmed death-ligand 1): A protein found on the surface of many healthy cells, and sometimes on cancer cells. It binds to a receptor (PD-1) on T-cells, sending an "off" signal that prevents the T-cell from attacking. High levels of PD-L1 on a tumor can help it evade the immune system.
Prophylactically: A term used to describe a measure taken to prevent a disease. For example, taking a medication prophylactically means taking it to prevent an infection from occurring, rather than to treat an existing one.
Schistosomiasis: A disease caused by parasitic flatworms called schistosomes. Infection occurs through contact with contaminated freshwater where certain types of snails that carry the parasite live.
Type I Interferon Response: A crucial part of the body's innate (first-line) immune defense against viruses. When a cell detects a virus, it releases signaling proteins called type I interferons (e.g., IFN-alpha, IFN-beta). These interferons alert neighboring cells to heighten their antiviral defenses and activate other immune cells like natural killer cells and macrophages to fight the infection. In the context of the podcast, the mRNA vaccine triggers this powerful antiviral alarm system, which inadvertently helps the immune system also recognize and fight cancer.